A Comparison of the Portfolio Low-carbohydrate Diet and the Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome: Study Protocol for a Randomized Controlled Trial

Overview

Journal Trials

Publisher Biomed Central

Specialties General Medicine
Pharmacology

Date 2023 Aug 9

PMID 37559131

Authors

Maryam Sharifi Najafabadi

Jalal Moludi

Yahya Salimi

Amir Saber

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine disorders among women of fertile age. Women with PCOS manifest clinical symptoms like menstrual dysfunction, hirsutism, insulin resistance, and hyperinsulinemia. As excessive amounts of insulin levels directly increase ovarian production of androgens, hyperinsulinemia and insulin resistance are considered as the pathogenesis factors of PCOS. The portfolio low-carbohydrate diet (PLCD) is a plant-based diet with 40% carbohydrates combined with five cholesterol-lowering foods and nutrients. On the other hand, the ketogenic diet (KD) is a nutritional protocol with 10% carbohydrates. The purpose of this study is to determine whether PLCD or KD is more effective in alleviating PCOS symptoms.

Methods: Forty-six overweight or obese women diagnosed with PCOS will be randomly stratified to receive either PLCD or KD for 8 weeks. Measures related to anthropometric and body composition, glucose, and insulin level, HOMA-IR, sex hormones, lipid profile, quality of life, dietary intake, physical activity, and Ferriman-Gallwey score of all participants will be accessed before and after the intervention.

Discussion: Since the first line treatment of PCOS is lifestyle adjustment including diet control and exercise, there has not been determined the optimal diet for this population of women yet. Hence, the goal of conducting this study is to determine whether the PLCD or the KD could have more advantageous effects on attenuating PCOS manifestations. The result of this investigation will give us new insight into curing this disease and will provide evidence-based recommendations for prescribing an optimal diet for PCOS women.

Trial Registration: IRCT20200912048693N3, Trial registered 2022-12-14. https://www.irct.ir/trial/67548.

Citing Articles

The effects of portfolio moderate-carbohydrate and ketogenic diets on anthropometric indices, metabolic status, and hormonal levels in overweight or obese women with polycystic ovary syndrome: a randomized controlled trial.

Sharifi M, Saber A, Moludi J, Salimi Y, Jahan-Mihan A Nutr J. 2024; 23(1):152.

PMID: 39617882 PMC: 11610292. DOI: 10.1186/s12937-024-01056-7.

References

Unfer V, Dinicola S, Russo M . A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?. Int J Mol Sci. 2023; 24(7). PMC: 10094056. DOI: 10.3390/ijms24076213. View

Deswal R, Narwal V, Dang A, Pundir C . The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2021; 13(4):261-271. PMC: 7879843. DOI: 10.4103/jhrs.JHRS_95_18. View

Cincione R, Losavio F, Ciolli F, Valenzano A, Cibelli G, Messina G . Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome. Int J Environ Res Public Health. 2021; 18(23). PMC: 8656706. DOI: 10.3390/ijerph182312490. View

Mei S, Ding J, Wang K, Ni Z, Yu J . Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients. Front Nutr. 2022; 9:876620. PMC: 9014200. DOI: 10.3389/fnut.2022.876620. View

Hoeger K, Dokras A, Piltonen T . Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2020; 106(3):e1071-e1083. DOI: 10.1210/clinem/dgaa839. View

Chiavaroli L, Nishi S, Khan T, Braunstein C, Glenn A, Mejia S . Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials. Prog Cardiovasc Dis. 2018; 61(1):43-53. DOI: 10.1016/j.pcad.2018.05.004. View

Thomson R, Buckley J, Noakes M, Clifton P, Norman R, Brinkworth G . The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008; 93(9):3373-80. DOI: 10.1210/jc.2008-0751. View

Bruni V, Capozzi A, Lello S . The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art. Reprod Sci. 2021; 29(3):668-679. DOI: 10.1007/s43032-021-00515-4. View

Unfer V, Russo M, Aragona C, Bilotta G, Oliva M, Bizzarri M . Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes. Biomedicines. 2023; 11(6). PMC: 10296526. DOI: 10.3390/biomedicines11061759. View

10.

Muscogiuri G, Barrea L, Laudisio D, Pugliese G, Salzano C, Savastano S . The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide. J Transl Med. 2019; 17(1):356. PMC: 6820992. DOI: 10.1186/s12967-019-2104-z. View

11.

Hsu Y, Huang C, Lin C . The effect of a low carbohydrate ketogenic diet with or without exercise on postpartum weight retention, metabolic profile and physical activity performance in postpartum mice. J Nutr Biochem. 2022; 102:108941. DOI: 10.1016/j.jnutbio.2022.108941. View

12.

Ruderman N, Xu X, Nelson L, Cacicedo J, Saha A, Lan F . AMPK and SIRT1: a long-standing partnership?. Am J Physiol Endocrinol Metab. 2010; 298(4):E751-60. PMC: 2853213. DOI: 10.1152/ajpendo.00745.2009. View

13.

Cincione I, Graziadio C, Marino F, Vetrani C, Losavio F, Savastano S . Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome. J Endocrinol Invest. 2022; 46(4):769-777. DOI: 10.1007/s40618-022-01943-y. View

14.

Glenn A, Boucher B, Kavcic C, Khan T, Paquette M, Kendall C . Development of a Portfolio Diet Score and Its Concurrent and Predictive Validity Assessed by a Food Frequency Questionnaire. Nutrients. 2021; 13(8). PMC: 8398786. DOI: 10.3390/nu13082850. View

15.

Krentowska A, Kowalska I . Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome. Diabetes Metab Res Rev. 2021; 38(1):e3464. DOI: 10.1002/dmrr.3464. View

16.

Ching H, Burke V, Stuckey B . Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf). 2007; 66(3):373-9. DOI: 10.1111/j.1365-2265.2007.02742.x. View

17.

Fauser B, Tarlatzis B, Rebar R, Legro R, Balen A, Lobo R . Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2011; 97(1):28-38.e25. DOI: 10.1016/j.fertnstert.2011.09.024. View

18.

Bilsborough S, Crowe T . Low-carbohydrate diets: what are the potential short- and long-term health implications?. Asia Pac J Clin Nutr. 2003; 12(4):396-404. View

19.

Amiri M, Ramezani Tehrani F, Nahidi F, Yarandi R, Behboudi-Gandevani S, Azizi F . Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis. Clin Endocrinol (Oxf). 2017; 87(3):217-230. DOI: 10.1111/cen.13389. View

20.

Ezeh U, Pisarska M, Azziz R . Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome. Hum Reprod. 2022; 37(3):553-564. PMC: 8888996. DOI: 10.1093/humrep/deac001. View